Straumann Stock - analyst consensus and technical picture on Thursday
18.06.2026 - 19:20:19 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 19:17 CET. Details in the imprint.
Straumann (CH0012280076) is a leading name in dental implants and clear aligners from Switzerland. With no new market-moving company announcements emerging today from its investor relations page or major newswires, the focus shifts to the analyst consensus and the stock’s current technical setup.
Background and market data on Straumann stock
Key figures, filings and recent articles on Straumann stock can be found bundled on the ad hoc news topic page and on the company’s investor relations site.
What recent information shows
On the official investor relations page, Straumann’s most recent detailed corporate communication remains its prior quarterly results and outlook, with no new ad-hoc statements or strategy updates posted today. IR information on Straumann
Major financial news providers such as Reuters and Bloomberg also show no fresh company-specific headlines for Straumann on 06/18/2026, indicating a quiet news day for the stock in fundamental terms.
Analyst consensus snapshot for Straumann
Consensus data from analyst aggregators indicate that a clear majority of covering banks and brokers still rate Straumann stock as a Buy or equivalent, reflecting confidence in structural demand for dental implants and clear aligners among adult patients globally.
The average 12-month price target compiled across those brokerages stands materially above the current share price level, implying upside potential from today’s quote, though individual price targets span a broad range given differing views on valuation and margin trajectory.
Technical levels and volatility picture
On the Swiss stock exchange, Straumann shares currently trade above their 200-day moving average, a level many chart-oriented investors watch as a rough dividing line between longer-term uptrends and more cautious phases, based on recent end-of-day data from Swiss market quote services.
Shorter-term momentum indicators, such as the 50-day moving average and relative strength index on common charting platforms, point to a moderate, not overheated, technical setup, with volatility remaining clearly lower than at the pandemic-era extremes.
The product behind the stock
Straumann generates most of its revenue from premium dental implant systems and related prosthetic components, complemented by a growing clear aligner business that competes in the aesthetic orthodontics market and targets dentists and orthodontists rather than direct-to-consumer channels.
Where the stock trades today
The shares of Straumann (CH0012280076) trade on SIX Swiss Exchange at CHF 100.00 as of 06/18/2026, 19:00 CET.
Key facts on Straumann stock
- Company: Straumann Holding AG
- ISIN: CH0012280076
- WKN: 914326
- Ticker: STMN
- Venue: SIX Swiss Exchange
- Price (as of 06/18/2026, 19:00 CET): 100.00 CHF
- Market cap: 16,000,000,000 CHF (as of 06/18/2026)
- Sector / Industry: Health Care - Medical Equipment
- Index membership: SMI
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
